Smith & Nephew Shares Hold Steady as Buyback and Cevian Stake Keep Turnaround in Focus
Smith & Nephew plc shares were almost flat in London on Monday, with Hargreaves Lansdown showing the stock at a 1,134p sell price and 1,135p buy price, up 1.5p, or 0.13%, while the FTSE 100 was down 0.32%. The move was small, but it mattered because the medical technology group remains in a tug of war between shareholder-return support and doubts about the speed of its turnaround. The same quote showed a market value of about £9.61 billion, a price-to-earnings ratio of 14.94 and a 2.56% dividend yield. A price-to-earnings ratio, or P/E, compares a company’s share price with its earnings and is often used as a quick valuation check. The latest support for the stock comes from Smith &